The Association for Cancer Immunotherapy Immunoguiding Program and the Cancer Immunotherapy Consortium of the Cancer Research Institute today announced a publication discussing the results of a unique collaborative vetting process which has now led to publication guidelines that increase transparency of immune response assessments.
The Cancer Research Institute and Stand Up To Cancer, in partnership with the American Association for Cancer Research, have issued a call for letters of intent from scientists and clinical investigators interested in forming the SU2C-CRI Cancer Immunology Translational Research Dream Team.
Pre-clinical study by scientists funded by Cancer Research Institute and Ludwig Institute for Cancer Research confirmed that combining chemotherapy and immunotherapy in cancer treatment enhances the immune system's ability to find and eliminate cancer cells.
CRI announced today its founding scientific and medical director Lloyd J. Old, M.D., regarded as the “Father of Modern Tumor Immunology,” died early this morning at his home in New York City from prostate cancer. He was 78 years old.
The Association for Cancer Immunotherapy Immunoguiding Program and the Cancer Immunotherapy Consortium of CRI published a joint paper discussing recent results of independent international, cross-laboratory immune assay harmonization studies.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Behind-the-scenes of a new based-on-a-true-story comedy web series, “Homesick,” about an American living in London with a woman battling cancer and her nine-year-old daughter.
Immunotherapy tripled the median progression-free survival rate among lung cancer patients compared to those who received only chemotherapy and radiation